A study to assess the safety, tolerability and pharmacokinetics of AZD9977 in Japanese healthy participants with single and multiple ascending dose administration

Trial Identifier: D6401C00005
Sponsor: AstraZeneca
Collaborator:
PAREXEL International
NCTID:: NCT03801967
Start Date: January 2019
Primary Completion Date: May 2019
Study Completion Date: May 2019
Condition: Congestive Heart Failure

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English version
UK English translation
Japanese translation

Trial Locations

Country Location
United Kingdom Harrow, United Kingdom, HA1 3UJ